دورية أكاديمية
287MO A phase 0 ‘trigger’ trial of pamiparib in newly diagnosed and recurrent glioblastoma patients
| العنوان: | 287MO A phase 0 ‘trigger’ trial of pamiparib in newly diagnosed and recurrent glioblastoma patients |
|---|---|
| المؤلفون: | Sanai, N., Mehta, S.N., Chang, Y-W., Jiang, J., Molloy, J., Pennington-Krygier, C., Harmon, J., Hong, A., Wanebo, J., Kennedy, W., Garcia, M., Barani, I., Yoo, W., Tovmasyan, A., Tien, A-C., Li, J. |
| المصدر: | Annals of Oncology ; volume 33, page S670 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2022.07.421 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2022.07.421Test https://api.elsevier.com/content/article/PII:S0923753422022724?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753422022724?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.F8E4456 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2022.07.421 |
|---|